Innovation in medical technologies to treat pain syndromes is changing the methods available to treat chronic pain. Many of these neuromodulation devices offer an opioid alternative and have sound scientific evidence supporting their use. We will examine the rationale, mechanisms of action, emerging applications, and future directions of neuromodulation approaches to treat pain.
Neuromodulation for Peripheral Neuropathies: What Is the Current Evidence?
SCS: What Do We Know Regarding the Science?
Optogenetic Neuromodulation: Silencing of Nociceptors
- Describe the obstacles and potential strategies to target treatment at the neural interface and the latest research on the mechanisms of pain control by neuromodulation.
- Discuss the current evidence for neuromodulation to treat peripheral neuropathies.
- Describe emerging neuromodulation pain therapies, variations now available for electrical stimulation, and new paradigms of therapy target selection.
- Diagnostic and Prognostic Anesthetic Blocks for Facet, Sacroiliac, and Knee Joint Pain: An Evidence-Based Update (202)
- Frontiers in Denervation for Chronic Pain: Sacroiliac Joint Complex, Knee, Shoulder, and Hip (206)
- Lumbar Facet Block and Radiofrequency Ablation International Consensus Guidelines Part 1 (210)
- Addressing Controversies Around Epidural Steroid Injections (212)
- Lumbar Facet Block and Radiofrequency Ablation International Consensus Guidelines Part 2 (214)